These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 15659296)
1. Celecoxib does not induce convulsions nor does it affect GABAA receptor binding activity in the presence of new quinolones in mice. Yoshino T; Noguchi M; Okutsu H; Kimoto A; Sasamata M; Miyata K Eur J Pharmacol; 2005 Jan; 507(1-3):69-76. PubMed ID: 15659296 [TBL] [Abstract][Full Text] [Related]
2. Hippocampus and frontal cortex are the potential mediatory sites for convulsions induced by new quinolones and non-steroidal anti-inflammatory drugs. Motomura M; Kataoka Y; Takeo G; Shibayama K; Ohishi K; Nakamura T; Niwa M; Tsujihata M; Nagataki S Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):223-7. PubMed ID: 1651287 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of new quinolones on GABA(A) receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: correlation with convulsive potency in vivo. Kawakami J; Yamamoto K; Asanuma A; Yanagisawa K; Sawada Y; Iga T Toxicol Appl Pharmacol; 1997 Aug; 145(2):246-54. PubMed ID: 9266796 [TBL] [Abstract][Full Text] [Related]
4. [Central stimulating effect of the combination of the new quinolone group of antimicrobials and nonsteroidal anti-inflammatory drugs in mice]. Murayama S; Hara Y; Ally A; Suzuki T; Tamagawa M Nihon Yakurigaku Zasshi; 1992 Jan; 99(1):13-8. PubMed ID: 1313777 [TBL] [Abstract][Full Text] [Related]
5. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice. Furuhama K; Akahane K; Tawara K; Takayama S Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442 [TBL] [Abstract][Full Text] [Related]
6. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Akahane K; Sekiguchi M; Une T; Osada Y Antimicrob Agents Chemother; 1989 Oct; 33(10):1704-8. PubMed ID: 2556076 [TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system. Kita H; Matsuo H; Takanaga H; Kawakami J; Yamamoto K; Iga T; Naito M; Tsuruo T; Asanuma A; Yanagisawa K; Sawada Y Antimicrob Agents Chemother; 1999 May; 43(5):1091-7. PubMed ID: 10223919 [TBL] [Abstract][Full Text] [Related]
8. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration]. Fukuda H; Kawamura Y Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111 [TBL] [Abstract][Full Text] [Related]
9. Effect of celecoxib on anticonvulsant activity of carbamazepine against maximal electroshock-induced convulsions in mice. Tayal V; Kalra BS; Chawla S Methods Find Exp Clin Pharmacol; 2008 Dec; 30(10):727-30. PubMed ID: 19271020 [TBL] [Abstract][Full Text] [Related]
10. [Effects of drugs on the convulsions induced by the combination of a new quinolone antimicrobial, enoxacin, and a nonsteroidal anti-inflammatory drug, fenbufen, in mice]. Hara Y; Ally A; Suzuki T; Murayama S Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):301-5. PubMed ID: 1446880 [TBL] [Abstract][Full Text] [Related]
11. Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Kim HJ; Chung JI; Lee SH; Jung YS; Moon CH; Baik EJ Brain Res; 2008 Feb; 1193():153-61. PubMed ID: 18178179 [TBL] [Abstract][Full Text] [Related]
12. Non-competitive inhibition of GABAA responses by a new class of quinolones and non-steroidal anti-inflammatories in dissociated frog sensory neurones. Yakushiji T; Shirasaki T; Akaike N Br J Pharmacol; 1992 Jan; 105(1):13-8. PubMed ID: 1317734 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system. Nakamura T; Fukuda H; Morita Y; Soumi K; Kawamura Y J Toxicol Sci; 2003 Feb; 28(1):35-45. PubMed ID: 12696183 [TBL] [Abstract][Full Text] [Related]
14. Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study. de Vries EF; Doorduin J; Vellinga NA; van Waarde A; Dierckx RA; Klein HC Nucl Med Biol; 2008 May; 35(4):459-66. PubMed ID: 18482683 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of GABAA receptor chloride channel by quinolones and norfloxacin-biphenylacetic acid hybrid compounds. Ito Y; Miyasaka T; Fukuda H; Akahane K; Kimura Y Neuropharmacology; 1996; 35(9-10):1263-9. PubMed ID: 9014141 [TBL] [Abstract][Full Text] [Related]
16. Levofloxacin, an optical isomer of ofloxacin, has attenuated epileptogenic activity in mice and inhibitory potency in GABA receptor binding. Akahane K; Tsutomi Y; Kimura Y; Kitano Y Chemotherapy; 1994; 40(6):412-7. PubMed ID: 7842825 [TBL] [Abstract][Full Text] [Related]
17. Possible intermolecular interaction between quinolones and biphenylacetic acid inhibits gamma-aminobutyric acid receptor sites. Akahane K; Kimura Y; Tsutomi Y; Hayakawa I Antimicrob Agents Chemother; 1994 Oct; 38(10):2323-9. PubMed ID: 7840564 [TBL] [Abstract][Full Text] [Related]
18. Characterization of quinolone antibacterial-induced convulsions and increases in nuclear AP-1 DNA- and CRE-binding activities in mouse brain. Ito Y; Ishige K; Aizawa M; Fukuda H Neuropharmacology; 1999 May; 38(5):717-23. PubMed ID: 10340309 [TBL] [Abstract][Full Text] [Related]
19. Interaction between enoxacin, a new antimicrobial, and nimesulide, a new non-steroidal anti-inflammatory agent in mice. Taniguchi Y; Deguchi Y; Noda K Inflamm Res; 1996 Aug; 45(8):376-9. PubMed ID: 8872509 [TBL] [Abstract][Full Text] [Related]
20. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil. Sharma B; Singh N; Singh M J Psychopharmacol; 2008 Mar; 22(2):162-71. PubMed ID: 18208924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]